Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN447479 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Egl Nine Homolog 3 (C. Elegans) (EGLN3) antibody
- Antibody type
- Monoclonal
- Description
- Protein G purified
- Reactivity
- Human, Rat, Simian
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- EG188e-d5
- Vial size
- 0.2 mL
- Storage
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references A DNA-binding Molecule Targeting the Adaptive Hypoxic Response in Multiple Myeloma Has Potent Antitumor Activity.
Prolyl hydroxylase 3 (PHD3) modulates catabolic effects of tumor necrosis factor-α (TNF-α) on cells of the nucleus pulposus through co-activation of nuclear factor κB (NF-κB)/p65 signaling.
Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues.
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.
Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].
Mysore VS, Szablowski J, Dervan PB, Frost PJ
Molecular cancer research : MCR 2016 Mar;14(3):253-66
Molecular cancer research : MCR 2016 Mar;14(3):253-66
Prolyl hydroxylase 3 (PHD3) modulates catabolic effects of tumor necrosis factor-α (TNF-α) on cells of the nucleus pulposus through co-activation of nuclear factor κB (NF-κB)/p65 signaling.
Fujita N, Gogate SS, Chiba K, Toyama Y, Shapiro IM, Risbud MV
The Journal of biological chemistry 2012 Nov 16;287(47):39942-53
The Journal of biological chemistry 2012 Nov 16;287(47):39942-53
Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues.
Soilleux EJ, Turley H, Tian YM, Pugh CW, Gatter KC, Harris AL
Histopathology 2005 Dec;47(6):602-10
Histopathology 2005 Dec;47(6):602-10
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.
Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW, Ratcliffe PJ, Gleadle JM
The Journal of biological chemistry 2004 Sep 10;279(37):38458-65
The Journal of biological chemistry 2004 Sep 10;279(37):38458-65
Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].
Stolze IP, Tian YM, Appelhoff RJ, Turley H, Wykoff CC, Gleadle JM, Ratcliffe PJ
The Journal of biological chemistry 2004 Oct 8;279(41):42719-25
The Journal of biological chemistry 2004 Oct 8;279(41):42719-25
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC